Background Withdrawal of prolonged nucleos(t)ide analogue (NA) treatment results in hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing ...

New evidence shows that human M cells act as fully fledged antigen-presenting cells, processing and presenting gluten peptides through a dendritic cell-like pathway that may shape early coeliac ...

The Centers for Disease Control and Prevention's vaccine advisory panel voted Friday to change the recommendation for when children should get their first dose of the hepatitis B vaccine. Instead of a ...

Dec 5 (Reuters) - Vaccine makers expressed concern on Friday's decision by a U.S. advisory panel to scrap its long-standing recommendation that all infants receive a hepatitis B vaccine at birth, a ...

A key vaccine panel at the Centers for Disease Control and Prevention voted 8-3 to nix a recommendation that all newborns be given a first dose of hepatitis B vaccine. The Friday vote, which came ...

Vaccine advisers to the Centers for Disease Control and Prevention voted Friday to no longer recommend all newborns receive a hepatitis B vaccine at birth, ending the panel’s decadeslong guidance that ...

The altered Advisory Committee on Immunization Practices, without new data to justify a reassessment, will no longer recommend universal hepatitis B vaccination at birth. The committee voted 8–3 to ...

In a move toward Health Secretary Robert F. Kennedy Jr.’s goal of upending vaccine policy, the committee recommended delaying the shots for infants whose mothers test negative for the virus. By ...

CDC vaccine panel votes to change guidelines for hepatitis B vaccines A vaccine advisory panel voted to change the guidelines for hepatitis B vaccines in newborns by delaying the jab two months.